| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |